Pfizer Inc. sell Wolfe Research
Start price
15.11.24
/
50%
€24.26
Target price
15.11.25
€23.67
Performance (%)
-12.53%
Price
07.08.25
€20.81
Summary
This prediction is currently active. The price of Pfizer Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.53%. Dividends of €0.41 are taken into consideration when calculating the performance. This prediction currently runs until 15.11.25. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 1.960% | 1.960% |
| iShares Core DAX® | 0.683% | 0.785% |
| iShares Nasdaq 100 | -1.457% | 3.734% |
| iShares Nikkei 225® | 0.931% | 2.958% |
| iShares S&P 500 | -2.022% | 2.444% |
Comments by Wolfe_Research for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) is now covered by analysts at Wolfe Research. They set an "underperform" rating and a $25.00 price target on the stock.
Ratings data for PFE provided by MarketBeat